A GÖRG team led by Dr. Frank Evers advised the German Vink Chemicals GmbH & Co. KG on the acquisition of the Technical Biocides and Fuel, Oil and Gas divisions from Schülke & Mary GmbH.
About Vink Chemicals
Vink Chemicals GmbH & Co. KG was founded in 2011 and is specialized in the development and formulation of biocidal products and active substances. Furthermore, the company focuses on the trade with specialty chemicals and develops a modern warehouse for hazardous goods as well as manufacturing facilities for the production of biocidal products. The product development and the quality management take place in Vink’s own laboratory. Vink Chemicals has an excellent network and is therefore able to act worldwide.
About Schülke & Mayr
Schülke & Mayr GmbH is a subsidiary of the Air Liquide Group in the healthcare sector and an expert in the fields of healthcare, personal care and industrial hygiene. For more than 130 years, the company has been designing, producing and supplying a wide range of disinfectants and antiseptics, mainly intended for the medical environment, in order to actively contribute to patient safety. schülke is present in over 100 countries through its subsidiaries and sales network and has more than 1,200 employees worldwide.
Advisors
GÖRG Partnerschaft von Rechtsanwälten mbB
Dr. Frank Evers, Partner, M&A/Corporate, Hamburg
Dr. Marcus Heinemann, Associated Partner, M&A/Corporate, Hamburg
Paul Caesar Rode, Associated Partner, M&A/Corporate, Hamburg
Dr. Jan-Henric M. Punte, LL.M. (Hull), Associate, M&A/Corporate, Hamburg
Dr. Frank Wilke, Partner, Employment Law, Cologne
Dr. Christian Bürger, Partner, Antitrust Law, Cologne
Dr. Melanie Ries, Associated Partner, IP/IT/Commercial, Munich
